NDC Product
Human Otc DrugCoxsackie NDC 43857-0111
- Generic Name
- Coxsackie B1, B4
- Dosage Form
- Liquid
- Route
- Oral
- Marketing
- UNAPPROVED HOMEOPATHIC
Active Listing
HUMAN COXSACKIEVIRUS B1
UNII ADL68M27WD
Substance Identification & Data
This profile provides standardized clinical and technical data for Human Coxsackievirus B1, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ADL68M27WD.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) 1427209. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
HUMAN COXSACKIEVIRUS B1
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
ADL68M27WD
The specific atomic composition represented as a molecular structure string.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
NCBI Taxonomy
138949
Unique numeric identifier used to specify biological species in the NCBI database.
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Human Coxsackievirus B1. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
Common Names & Synonyms
ENTEROVIRUS HUMAN ENTEROVIRUS B SEROGROUP COXSACKIEVIRUS SEROTYPE B1
HUMAN COXSACKIEVIRUS B1
HUMAN ENTEROVIRUS B COXSACKIEVIRUS B1
HUMAN ENTEROVIRUS B SEROGROUP COXSACKIEVIRUS SEROTYPE B1
NDC Products Containing HUMAN COXSACKIEVIRUS B1
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
